[go: up one dir, main page]

AR040908A1 - S - (+) -3- ((1- (2- (2,3-DIHIDRO-1HINDOL3IL) ETIL) 3,6-DIHIDRO- 2H- PIRIDIN-4-IL)) - 6-CHLORINE-1H-INDOL, ADDITION SALTS OF THE SAME ACID AND PHARMACEUTICAL COMPOSITION - Google Patents

S - (+) -3- ((1- (2- (2,3-DIHIDRO-1HINDOL3IL) ETIL) 3,6-DIHIDRO- 2H- PIRIDIN-4-IL)) - 6-CHLORINE-1H-INDOL, ADDITION SALTS OF THE SAME ACID AND PHARMACEUTICAL COMPOSITION

Info

Publication number
AR040908A1
AR040908A1 AR20030103075A ARP030103075A AR040908A1 AR 040908 A1 AR040908 A1 AR 040908A1 AR 20030103075 A AR20030103075 A AR 20030103075A AR P030103075 A ARP030103075 A AR P030103075A AR 040908 A1 AR040908 A1 AR 040908A1
Authority
AR
Argentina
Prior art keywords
dihidro
pharmaceutical composition
indol
1hindol3il
piridin
Prior art date
Application number
AR20030103075A
Other languages
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR040908A1 publication Critical patent/AR040908A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuesto de S-(+)-3-{1-[2-2,3-dihidro-1H-indol-3-il)etil]3,6-dihidro-2H-piridin-4-il}-6-cloro-1H-indol que tiene la fórmula 1 o una sal farmacéuticamente aceptable del mismo y a su uso para la preparación de una composición farmacétuca para el tratamiento de enfermedades y desórdenes que responden a la inhibición de la recaptación 5-ht y/o a las enfermedades y desórdenes que responden al antegonismo receptor de dopamina D4. La composición farmacéutica. Estos compuesto son útiles en el tratamiento de los desórdenes de la ansiedad, la depresión y otros desórdenes afectivos.Compound of S - (+) - 3- {1- [2-2,3-dihydro-1H-indol-3-yl) ethyl] 3,6-dihydro-2H-pyridin-4-yl} -6-chloro -1H-indole having the formula 1 or a pharmaceutically acceptable salt thereof and its use for the preparation of a pharmaceutical composition for the treatment of diseases and disorders that respond to the inhibition of 5-ht reuptake and / or diseases and Disorders that respond to dopamine D4 receptor antagonism. The pharmaceutical composition These compounds are useful in the treatment of anxiety disorders, depression and other affective disorders.

AR20030103075A 2002-08-29 2003-08-26 S - (+) -3- ((1- (2- (2,3-DIHIDRO-1HINDOL3IL) ETIL) 3,6-DIHIDRO- 2H- PIRIDIN-4-IL)) - 6-CHLORINE-1H-INDOL, ADDITION SALTS OF THE SAME ACID AND PHARMACEUTICAL COMPOSITION AR040908A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200201272 2002-08-29

Publications (1)

Publication Number Publication Date
AR040908A1 true AR040908A1 (en) 2005-04-20

Family

ID=38812814

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030103075A AR040908A1 (en) 2002-08-29 2003-08-26 S - (+) -3- ((1- (2- (2,3-DIHIDRO-1HINDOL3IL) ETIL) 3,6-DIHIDRO- 2H- PIRIDIN-4-IL)) - 6-CHLORINE-1H-INDOL, ADDITION SALTS OF THE SAME ACID AND PHARMACEUTICAL COMPOSITION

Country Status (3)

Country Link
AR (1) AR040908A1 (en)
TW (1) TW200406403A (en)
UY (1) UY27960A1 (en)

Also Published As

Publication number Publication date
UY27960A1 (en) 2004-03-31
TW200406403A (en) 2004-05-01

Similar Documents

Publication Publication Date Title
SE0302760D0 (en) New compounds
UY29919A1 (en) SUBSTITUTED DERIVATIVES OF 3,4-DIHYDROISOQUINOLIN-1-AMINO-TRIFLUOROACETATE, ITS PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
MXPA04007414A (en) Substituted indoles as alpha-1 agonists.
PA8575401A1 (en) DERIVATIVES OF BENZOCONDENSED HETEROARILAMIDE OF USEFUL TIENOPIRIDINS AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND METHODS FOR USE
UY31027A1 (en) DERIVATIVES OF TETRAHYDROINDOL AND TETRAHYDROINDAZOL
DE602004008098D1 (en) SUBSTITUTED 2H-Ä1,2,4ÜTRIAZOLOÄ4,3-AÜPYRAZINE AS GSK-3 INHIBITORS
SE0200979D0 (en) New compounds
ATE384058T1 (en) THIAZOLE DERIVATIVES
HN2005000484A (en) NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
UY26968A1 (en) THERAPEUTIC AGENTS
EA200970585A1 (en) BENZAMIDE DERIVATIVES AS AGONISTS OF EP RECEPTORS
ECSP088973A (en) IMIDAZOL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE SYNTHETIC KINASE GLYCOGEN (GSK3)
EA201070588A1 (en) DERIVATIVES 1,2,3-TRIAZOLE FOR USE AS STAROIL-COA DESSATRASE AS AN INHIBITORS
UY30316A1 (en) SUBSTITUTED DERIVATIVES OF BENZAMIDS, NICOTINAMIDS, PROPANAMIDS, ACETAMIDS AND CARBOXAMIDS N- (2- (PIPERIDIN-1-ILMETIL) CICLOHEXIL) REPLACED, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS
NO20025641D0 (en) Substituted 1-aminoalkyl lactams and their use as muscarinic receptor antagonists
EA200601194A1 (en) NEW DERIVATIVES OF BENZOFURANE USED FOR THE PREVENTION OR TREATMENT OF DISTURBANCES ASSOCIATED WITH 5-HT-RECEPTOR
AR028624A1 (en) HETEROCICLILALQUILAMINAS AS ANTAGONISTS OF MUSCARINIC RECEPTORS
BRPI0411936A (en) compound, process for its preparation, pharmaceutical composition comprising the same, use of a compound, methods for the treatment and prophylaxis of central nervous system disorders, eating disorders and obesity
BR0316950A (en) Indazole derivatives as crf antagonists
PA8426801A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS.
SV2007002526A (en) DIARILSULFONA SULFONAMIDS AND THE USE OF THE SAME REF. P1018
HUP0402515A2 (en) Novel substituted n-[4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1h-pyrazole-5-carboxamides as inhibitors of factor xa, their use and pharmaceutical compositions containing them
AR054707A1 (en) DERIVATIVES OF OCTAHIDROPIRROLO 3,4-C PIRROL, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR037427A1 (en) QUINOLINE COMPOUND, USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, PROCEDURE TO PREPARE IT AND UTILITY QUINOLINE COMPOUNDS AS INTERMEDIARIES IN THIS PROCEDURE
BRPI0411293A8 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, PROCESS FOR PREPARING A COMPOUND, AND USE OF A COMPOUND

Legal Events

Date Code Title Description
FA Abandonment or withdrawal